SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-031266
Filing Date
2024-10-15
Accepted
2024-10-15 16:45:13
Documents
19
Period of Report
2024-10-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20241014_8k.htm   iXBRL 8-K 28787
2 EXHIBIT 5.1 ex_732587.htm EX-5.1 15177
7 w01.jpg GRAPHIC 2978
8 w02.jpg GRAPHIC 11676
9 w03.jpg GRAPHIC 9487
10 w04.jpg GRAPHIC 3149
  Complete submission text file 0001437749-24-031266.txt   234219

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20241015.xsd EX-101.SCH 3892
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20241015_def.xml EX-101.DEF 13444
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20241015_lab.xml EX-101.LAB 17671
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20241015_pre.xml EX-101.PRE 13421
21 EXTRACTED XBRL INSTANCE DOCUMENT govx20241014_8k_htm.xml XML 4782
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 241372383
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)